Liver Disease

Advertisement

cGxPJobs Banner

Rivus Pharmaceuticals Reports Positive Phase 2 Results for HU6 in MASH Patients

CHARLOTTESVILLE, Va., and SOUTH SAN FRANCISCO, Calif., November 7, 2025 — Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company pioneering...

By cGxPwire Editor
November 7, 2025

Read More

Roche Completes Acquisition of 89bio in Strategic Biotech Expansion

Basel, Switzerland – October 30, 2025 — Roche Holding AG (SIX: RO, ROG; OTCQX: RHHBY) has successfully completed its...

By cGxPwire Editor
October 30, 2025

Read More

Advertisement

cGxPJobs

Directory